Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Choose from credit cards with zero annual fees that offer cash back rewards. Keep all your rewards and maximize your savings.
23,592 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Analysts warn that the Social Security funding gap could reach a tipping point in the early 2030s. If policy action s...
With stock markets choppy and inflation easing, a growing number of financial planners urge a bridge strategy: withdr...
Settle in with a cup of coffee and a clear market view. This guide bundles 10 weekend reads that translate complex fi...
A renewed debate over gifting beyond required minimum distributions challenges retirees to balance tax costs with lon...
NovaCore Technologies enters the second half of 2026 with a multi-year backlog, AI revenue momentum, and cloud growth...
A quarterly data snapshot reveals moves by the wealthiest fund managers. This piece dives into why these billionaire ...
Nvidia's surge in AI chips is reshaping markets, and some analysts frame it as a $200 billion warning for rivals like...
Tucson stands out as the most practical Arizona city for most retirees, offering affordable housing, strong healthcar...
Investors are watching a potential shift at HubSpot as AI features expand across its platform. This guide breaks down...
A precise timing decision on when to claim Social Security could unlock substantial monthly gains for some retirees. ...
Palantir has cooled off after a blazing run, but analysts say there's still meaningful upside. This guide breaks down...